Voters should care about this bill because it addresses a critical aspect of drug safety. Currently, while the FDA can request recalls for most drugs, its power to *mandate* a recall is more limited, primarily to controlled substances and certain medical devices. This means that if a company is slow to act or refuses to voluntarily recall a dangerous non-controlled drug, the FDA's options for swift enforcement are constrained.

If this bill becomes law, the FDA would have a more consistent and powerful tool to remove any unsafe drug from the market quickly, regardless of its classification. This could lead to a faster response to contamination issues, manufacturing defects, or unexpected side effects, potentially preventing more people from being harmed. If the bill does not pass, the FDA would continue to rely on voluntary recalls for many drugs, which some argue might not always be sufficient to protect public health in a timely manner.